Кветиапин

Quetiapine is a second-generation atypical antipsychotic of the dibenzothiazepine class, structurally related to clozapine. Developed by AstraZeneca and first approved by the FDA in 1997, it is prescribed for schizophrenia, bipolar disorder, and as an adjunct in major depressive disorder. It is also widely used off-label for insomnia, anxiety, and other conditions. While recreational use is uncommon, reports of misuse have emerged, primarily driven by its sedative and anxiolytic properties.

Also known as: Derin, Seroquel, Xeroquel, Ketilept, Ketipinor

Classification

Chemical: Medicine
Psychoactive: Depressant
Tag: Antipsychotic
Tag: Dibenzothiazepine
Tag: Dibenzothiazepine derivative
Tag: Pharmaceutical

Effects

Sedation
Headache
Fatigue
Dry Mouth
Increased Blood Pressure
Akathisia Like Movement
Thought Deceleration
Emotion Suppression
Information Processing Suppression
Language Suppression
Amnesia
Anxiety Suppression
Dehydration
Appetite Change
Entity Imagery
Open Eye Visuals
Voices
Internal Hallucination

Routes of Administration

Oral

Dosage

Heavy: 300-800 mg
Light: 25-100 mg
Common: 100-400 mg
Strong: 400 mg
Threshold: 10 mg

Duration

Onset: 0.33-0.67 h
Peak: 1.5-6 h
Offset: 6-7 h
After Effects: 24-48 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu